台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    44.25
  • 漲跌
    ▼0.05
  • 漲幅
    -0.11%
  • 成交量
    59
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-元大-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0404/2005/0405/1802/0202/1203/0603/0806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1202/22404244464850May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/041243.9000.0045.00121527.86%
2025/02/24046.3000.0045.8501560.00%
2025/02/20044.6500.0045.2501480.00%
2025/01/2200.00542.4542.30-5228-2.19%
2024/12/09044.1500.0043.8006000.00%
2024/11/19345.3000.0045.4536880.44%
2024/11/18144.6000.0044.1016990.14%
2024/11/1300.00047.5047.2007190.00%
2024/11/12147.4000.0047.3517260.14%
2024/11/11148.1500.0048.3517310.14%
2024/11/08449.03948.8348.60-5735-0.68%
2024/10/30151.9000.0050.5017770.13%
2024/10/284355.092553.4352.60187562.38%
2024/10/25552.1600.0054.4056450.77%
2024/10/22149.70449.3049.60-3646-0.46%
2024/10/17351.5000.0050.5038500.35%
2024/10/11148.9500.0048.9511,0630.09%
2024/10/04153.1000.0052.4011,0520.10%
2024/09/30354.70155.7054.4021,0460.19%
2024/09/27254.8000.0054.7021,0350.19%
2024/09/2400.00153.8053.40-11,019-0.10%
2024/09/2000.00154.5055.00-11,023-0.10%
2024/09/191155.391153.8853.2009950.00%
2024/09/13147.8500.0047.8019670.10%
2024/08/2100.00251.5050.60-2948-0.21%
2024/08/2000.001051.4250.90-10943-1.06%
2024/08/14247.1000.0047.0529010.22%
2024/08/13347.2300.0047.1038940.34%
2024/08/07150.50151.0050.7008560.00%
2024/08/06249.4000.0049.0028410.24%
2024/08/05247.7000.0047.7028180.24%
2024/08/01356.0000.0055.4038040.37%
2024/07/2900.001057.5056.90-10788-1.27%
2024/07/26052.3000.0054.5007760.00%
2024/07/23855.4000.0054.1087701.04%
2024/07/22257.10159.1056.2017520.13%
2024/07/191060.1610.158.4658.10-0.1735-0.01%
2024/07/181459.941362.0862.2016580.15%
2024/07/171058.132858.5858.90-18543-3.31%
2024/07/1200.00447.3047.30-4328-1.22%
2024/07/10443.4400.0043.3543191.25%
2024/07/0800.00345.9544.70-3315-0.95%
2024/07/05245.0500.0045.6523120.64%
2024/07/04144.6500.0044.8513100.32%
2024/06/212146.3000.0045.20212588.11%
2024/06/19147.50147.7547.9502240.00%
2024/06/17145.35844.8445.35-7187-3.74%
2024/06/0700.00242.1042.60-2151-1.32%
2024/05/22243.6000.0043.2521741.14%
2024/04/2900.00341.4541.30-3183-1.64%
2024/04/24240.9300.0041.1021831.09%
2024/04/18042.3600.0041.9001820.00%
2024/04/17141.9500.0041.7511830.55%
2024/04/16043.0000.0041.2501840.00%
2024/04/15042.7800.0042.3001870.00%
2024/04/01044.5500.0044.4001930.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音